Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa

BMC Urology

Volumn 13, Issue , 2013, Pages

  Tindall, Elizabeth A ^a,b   Bornman, Ms Riana ^c   Van Zyl, Smit ^d   Segone, Alpheus M ^d   Monare, L Richard ^d   Venter, Philip A ^d   Hayes, Vanessa M ^a,b,d,e  

^a J CRAIG VENTER INSTITUTE   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d UNIVERSITY OF LIMPOPO   (South Africa)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

African ancestry; Aggressive disease; Epidemiology; Genetics; Pilot analysis; Prostate cancer; Risk factors; Southern Africa

Indexed keywords

ACETYLSALICYLIC ACID; PROSTATE SPECIFIC ANTIGEN;

ALLELE; ALOPECIA; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ERECTILE DYSFUNCTION; FAMILY HISTORY; FOLLOW UP; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PROSTATE CANCER; SEXUAL BEHAVIOR; SOUTH AFRICA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MEN'S HEALTH; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; RISK FACTORS; SOUTH AFRICA;

EID: 84891005373     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-13-74     Document Type: Article

References (48)

1. Mortality results from a randomized prostate-cancer screening trial. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, et al. N Engl J Med 2009 360 13 1310 1319 10.1056/NEJMoa0810696 19297565
2. Screening and prostate-cancer mortality in a randomized European study. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al. N Engl J Med 2009 360 13 1320 1328 10.1056/NEJMoa0810084 19297566
3. Prostate-specific antigen screening in the United States vs in the European randomized study of screening for prostate cancer-Rotterdam. Wever EM, Draisma G, Heijnsdijk EA, Roobol MJ, Boer R, Otto SJ, de Koning HJ, J Natl Cancer Inst 2010 102 5 352 355 10.1093/jnci/djp533 20142584
4. Clinical practice. Screening for prostate cancer. Hoffman RM, N Engl J Med 2011 365 21 2013 2019 10.1056/NEJMcp1103642 22029754
5. Prostate cancer: diagnostic performance of the PCA3 urine test. Lee GL, Dobi A, Srivastava S, Nat Rev Urol 2011 8 3 123 124 10.1038/nrurol.2011.10 21394175
6. Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. Helfand BT, Kan D, Modi P, Catalona WJ, Prostate 2011 71 4 394 402 10.1002/pros.21253 20860009
7. Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study. Johansson M, Holmström B, Hinchliffe SR, Bergh A, Stenman UH, Hallmans G, Wiklund F, Stattin P, Int J Cancer 2012 130 1 129 137 10.1002/ijc.25986 21328341
8. Epidemiology of prostate cancer in Africa: another step in the understanding of the disease? Delongchamps NB, Singh A, Haas GP, Curr Probl Cancer 2007 31 3 226 236 10.1016/j.currproblcancer.2007.01.004 17543950 (Pubitemid 46818421)
9. Part I: Cancer in Indigenous Africans-burden, distribution, and trends. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H, Lancet Oncol 2008 9 7 683 692 10.1016/S1470-2045(08)70175-X 18598933 (Pubitemid 351878054)
10. Prostate cancer among different racial groups in the Western Cape: presenting features and management. Heyns CF, Fisher M, Lecuona A, van der Merwe A, S Afr Med J 2011 101 4 267 270 21786733
11. A retrospective study on pathologic features and racial disparities in prostate cancer. Bigler SA, Pound CR, Zhou X, Prostate Cancer 2011 2011 239460 22135747
12. Racial differences in prostate cancer treatment outcomes: a systematic review. Peters N, Armstrong K, Cancer Nurs 2005 28 2 108 118 15815180 (Pubitemid 40489235)
13. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Haas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G, Can J Urol 2008 15 1 3866 3871 18304396
14. Prostate cancer in black and white Americans. Reddy S, Shapiro M, Morton R, Brawley OW, Cancer Metastasis Rev 2003 22 1 83 86 10.1023/A:1022216119066 12716039 (Pubitemid 36363516)
15. Evaluating genetic risk for prostate cancer among Japanese and Latinos. Cheng I, Chen GK, Nakagawa H, He J, Wan P, Lurie C, Shen J, Sheng X, Pooler LC, Crenshaw AT, et al. Cancer Epidemiol Biomarkers Prev 2012 21 11 2048 2058 10.1158/1055-9965.EPI-12-0598 22923026
16. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, Kawaguchi T, Tsunoda T, Inazawa J, Kamatani N, Ogawa O, et al. Nat Genet 2010 42 9 751 754 10.1038/ng.635 20676098
17. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Akamatsu S, Takata R, Haiman CA, Takahashi A, Inoue T, Kubo M, Furihata M, Kamatani N, Inazawa J, Chen GK, et al. Nat Genet 2012 44 4 426 429 S421 10.1038/ng.1104 22366784
18. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, et al. Nat Genet 2011 43 6 570 573 10.1038/ng.839 21602798
19. Genome-wide association studies in cancer-current and future directions. Chung CC, Magalhaes WC, Gonzalez-Bosquet J, Chanock SJ, Carcinogenesis 2010 31 1 111 120 10.1093/carcin/bgp273 19906782
20. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia. Lagiou A, Samoli E, Georgila C, Minaki P, Barbouni A, Tzonou A, Trichopoulos D, Lagiou P, Eur J Cancer Prev 2008 17 4 336 339 10.1097/CEJ.0b013e3282f5221e 18562958
21. Does exposure to agricultural chemicals increase the risk of prostate cancer among farmers? Parent ME, Désy M, Siemiatycki J, Mcgill J Med 2009 12 1 70 77 19753293
22. Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Leitzmann MF, Rohrmann S, Clin Epidemiol 2012 4 1 11
23. Male pattern baldness and prostate cancer risk in a population-based case-control study. Wright JL, Page ST, Lin DW, Stanford JL, Cancer Epidemiol 2010 34 2 131 135 10.1016/j.canep.2010.02.003 20206591
24. Multiple regions within 8q24 independently affect risk for prostate cancer. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, et al. Nat Genet 2007 39 5 638 644 10.1038/ng2015 17401364 (Pubitemid 46676106)
25. Statistical significance for genomewide studies. Storey JD, Tibshirani R, Proc Natl Acad Sci U S A 2003 100 16 9440 9445 10.1073/pnas.1530509100 12883005 (Pubitemid 37033947)
26. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, Journal of the Royal Statistical Society, Series B (Methodological) 1995 57 1 289 300
27. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. DeLong ER, DeLong DM, Clarke-Pearson DL, Biometrics 1988 44 3 837 845 10.2307/2531595 3203132
28. Multiple loci on 8q24 associated with prostate cancer susceptibility. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Jhavar S, Saunders E, et al. Nat Genet 2009 41 10 1058 1060 10.1038/ng.452 19767752
29. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, et al. Proc Natl Acad Sci U S A 2006 103 38 14068 14073 10.1073/pnas.0605832103 16945910 (Pubitemid 44452981)
30. The usefulness of prostate cancer genome-wide association studies. Coetzee GA, J Urol 2012 187 1 9 10 10.1016/j.juro.2011.10.057 22088348
31. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. Schenk JM, Kristal AR, Arnold KB, Tangen CM, Neuhouser ML, Lin DW, White E, Thompson IM, Am J Epidemiol 2011 173 12 1419 1428 10.1093/aje/kwq493 21540324
32. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. McNeal JE, Redwine EA, Freiha FS, Stamey TA, Am J Surg Pathol 1988 12 12 897 906 10.1097/00000478-198812000-00001 3202246 (Pubitemid 19011040)
33. Methodological challenges of genome-wide association analysis in Africa. Teo YY, Small KS, Kwiatkowski DP, Nat Rev Genet 2010 11 2 149 160 20084087
34. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL, Cancer Epidemiol Biomarkers Prev 2011 20 6 1196 1203 10.1158/1055-9965.EPI-10-1299 21467234
35. New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. Nam RK, Zhang W, Siminovitch K, Shlien A, Kattan MW, Klotz LH, Trachtenberg J, Lu Y, Zhang J, Yu C, et al. Cancer Biol Ther 2011 12 11 997 1004 10.4161/cbt.12.11.18366 22130093
36. Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy? Elshafei A, Moussa AS, Hatem A, Ethan V, Panumatrassamee K, Hernandez AV, Jones JS, Urology 2013 81 4 826 830 10.1016/j.urology.2012.10.074 23434102
37. Prostate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE Study. Thomas JA, Gerber L, Bañez LL, Moreira DM, Rittmaster RS, Andriole GL, Freedland SJ, Cancer Epidemiol Biomarkers Prev 2012 21 4 576 581 10.1158/1055-9965.EPI-11-1017 22315364
38. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W, Boyle P, Hopper JL, Cancer Epidemiol Biomarkers Prev 2002 11 6 549 553 12050096 (Pubitemid 34615162)
39. Epidemiological aspects of neoplasms in diabetes. Nicolucci A, Acta Diabetol 2010 47 2 87 95 10.1007/s00592-010-0187-3 20376506
40. Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden. Fall K, Garmo H, Gudbjörnsdottir S, Stattin P, Zethelius B, Cancer Epidemiol Biomarkers Prev 2013 22 6 1102 1109 10.1158/1055-9965.EPI-12-1046 23580698
41. Association between metabolic syndrome, diabetes mellitus and prostate cancer risk. Lawrence YR, Morag O, Benderly M, Boyko V, Novikov I, Dicker AP, Goldbourt U, Behar S, Barchana M, Wolf I, Prostate Cancer Prostatic Dis 2013 16 2 181 186 10.1038/pcan.2012.54 23399780
42. Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. Snyder CF, Stein KB, Barone BB, Peairs KS, Yeh HC, Derr RL, Wolff AC, Carducci MA, Brancati FL, Prostate Cancer Prostatic Dis 2010 13 1 58 64 10.1038/pcan.2009.39 20145631
43. New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication. Gunter JH, Sarkar PL, Lubik AA, Nelson CC, Int J Cell Biol 2013 2013 834684 23573093
44. Frequency of ejaculation and risk of prostate cancer. Giles GG, Severi G, English DR, Hopper JL, JAMA 2004 292 3 329 author reply 329 15265846 (Pubitemid 38944255)
45. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Veitonmäki T, Tammela TL, Auvinen A, Murtola TJ, Eur J Cancer 2013 49 4 938 945 10.1016/j.ejca.2012.09.030 23079475
46. DDT contamination from indoor residual spraying for malaria control. Van Dyk JC, Bouwman H, Barnhoorn IE, Bornman MS, Sci Total Environ 2010 408 13 2745 2752 10.1016/j.scitotenv.2010.03.002 20381127
47. DDT and urogenital malformations in newborn boys in a malarial area. Bornman R, de Jager C, Worku Z, Farias P, Reif S, BJU Int 2010 106 3 405 411 10.1111/j.1464-410X.2009.09003.x 19849691
48. Out of Africa: modern human origins special feature: explaining worldwide patterns of human genetic variation using a coalescent-based serial founder model of migration outward from Africa. DeGiorgio M, Jakobsson M, Rosenberg NA, Proc Natl Acad Sci U S A 2009 106 38 16057 16062 10.1073/pnas.0903341106 19706453